Short-term gestation, long-term risk: prematurity and chronic kidney disease

J Bryan Carmody1, Jennifer R Charlton

  • 1Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA.

Pediatrics
|May 15, 2013
PubMed

Insights

Premature birth and low birth weight may lead to fewer nephrons, increasing the risk of chronic kidney disease (CKD) later in life. Further research is needed to assess and manage this risk in affected infants.

Area of Science:

  • Neonatal Medicine
  • Nephrology
  • Developmental Biology

Background:

  • Neonatal intensive care advances allow premature and low birth weight (LBW) infants to survive, but long-term kidney health consequences remain unclear.
  • Premature and LBW infants often have fewer immature nephrons at birth and face developmental challenges.
  • Potential insults include hemodynamic changes, nephrotoxic drugs, infections, and poor nutrition, which can impair kidney development or cause nephron loss.

Purpose of the Study:

  • To review evidence linking premature birth and LBW to impaired nephrogenesis and increased risk of chronic kidney disease (CKD).
  • To discuss the theoretical basis (Brenner's hypothesis) and experimental/observational data supporting this risk.
  • To highlight the lack of established screening and management guidelines for CKD in this population.

Main Methods:

  • Review of existing scientific literature, including theoretical frameworks, experimental studies, and observational data.
  • Analysis of factors affecting nephrogenesis and nephron number in premature and LBW infants.
  • Examination of the relationship between acute kidney injury and long-term CKD risk.

Main Results:

  • Premature and LBW infants may start with reduced nephron counts and are susceptible to further nephron loss.
  • Acute kidney injury is identified as a potential significant risk factor for developing CKD.
  • Brenner's hypothesis suggests reduced nephron number leads to hyperfiltration, hypertension, and progressive kidney damage.

Conclusions:

  • There is a theoretical and evidence-based concern for an increased risk of CKD in individuals born prematurely or with LBW.
  • The precise prevalence of CKD in this population is unknown, necessitating further investigation.
  • Individualized, risk-based assessments are recommended for premature and LBW infants to monitor for potential long-term kidney issues.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...